Amniotic membrane (AM)–derived products have been successfully used in ophthalmology, plastic surgery, and wound care, but little is known about their potential applications in orthopaedic sports medicine.
Purpose:
To provide an updated review of the basic science and preclinical and clinical data supporting the use of AM-derived products and to review their current applications in sports medicine.
Study Design:
Systematic review.
Methods:
A systematic search of the literature was conducted using the Medline, EMBASE, and Cochrane databases. The search term amniotic membrane was used alone and in conjunction with stem cell, orthopaedic, tissue engineering, scaffold, and sports medicine.
Results:
The search identified 6870 articles, 80 of which, after screening of the titles and abstracts, were considered relevant to this study. Fifty-five articles described the anatomy, basic science, and nonorthopaedic applications of AM-derived products. Twenty-five articles described preclinical and clinical trials of AM-derived products for orthopaedic sports medicine. Because the level of evidence obtained from this search was not adequate for systematic review or meta-analysis, a current concepts review on the anatomy, physiology, and clinical uses of AM-derived products is presented.
Conclusion:
Amniotic membranes have many promising applications in sports medicine. They are a source of pluripotent cells, highly organized collagen, antifibrotic and anti-inflammatory cytokines, immunomodulators, and matrix proteins. These properties may make it beneficial when applied as tissue engineering scaffolds, improving tissue organization in healing, and treatment of the arthritic joint. The current body of evidence in sports medicine is heavily biased toward in vitro and animal studies, with little to no human clinical data. Nonetheless, 14 companies or distributors offer commercial AM products. The preparation and formulation of these products alter their biological and mechanical properties, and a thorough understanding of these differences will help guide the use of AM-derived products in sports medicine research.
BarboniBCuriniVRussoV. Indirect co-culture with tendons or tenocytes can program amniotic epithelial cells towards stepwise tenogenic differentiation. PLoS One. 2012;7(2):e30974.
4.
BarboniBRussoVCuriniV. Achilles tendon regeneration can be improved by amniotic epithelial cell allotransplantation. Cell Transplant. 2012;21(11):2377-2395.
5.
ChangCJYenMLChenYC. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells. 2006;24(11):2466-2477.
6.
ChughJPJainPSenR. Comparative analysis of fresh and dry preserved amniotic membrane transplantation in partial limbal stem cell deficiency. Int Ophthalmol. 2015;35(3):347-355.
7.
CobanISatogluISGultekinATunaBTatariHFidanM. Effects of human amniotic fluid and membrane in the treatment of Achilles tendon ruptures in locally corticosteroid-induced Achilles tendinosis: an experimental study on rats. Foot Ankle Surg. 2009;15(1):22-27.
8.
DeMillSLGranataJDMcAlisterJEBerletGCHyerCF. Safety analysis of cryopreserved amniotic membrane/umbilical cord tissue in foot and ankle surgery: a consecutive case series of 124 patients. Surg Technol Int. 2014;25:257-261.
9.
DemirkanFColakogluNHerekOErkulaG. The use of amniotic membrane in flexor tendon repair: an experimental model. Arch Orthop Trauma Surg. 2002;122(7):396-399.
10.
Diaz-PradoSRendal-VazquezMEMuinos-LopezE. Potential use of the human amniotic membrane as a scaffold in human articular cartilage repair. Cell Tissue Bank. 2010;11(2):183-195.
11.
FairbairnNGRandolphMARedmondRW. The clinical applications of human amnion in plastic surgery. J Plast Reconstr Aesthet Surg. 2014;67(5):662-675.
12.
FetterolfDESnyderRJ. Scientific and clinical support for the use of dehydrated amniotic membrane in wound management. Wounds. 2012;24(10):299-307.
13.
GalaskRPSnyderIS. Antimicrobial factors in amniotic fluid. Am J Obstet Gynecol. 1970;106(1):59-65.
14.
GarciaDLongoUGVaqueroJ. Amniotic membrane transplant for articular cartilage repair: an experimental study in sheep. Curr Stem Cell Res Ther. 2014;10(1):77-83.
15.
GobertMLafailleJJ. Maternal-fetal immune tolerance, block by block. Cell. 2012;150(1):7-9.
16.
HanselmanAETidwellJESantrockRD. Cryopreserved human amniotic membrane injection for plantar fasciitis: a randomized, controlled, double-blind pilot study. Foot Ankle Int. 2015;36(2):151-158.
17.
HaoYMaDHHwangDGKimWSZhangF. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000;19(3):348-352.
18.
IlancheranSMichalskaAPehGWallaceEMPeraMManuelpillaiU. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod. 2007;77(3):577-588.
JinCZParkSRChoiBHLeeKYKangCKMinBH. Human amniotic membrane as a delivery matrix for articular cartilage repair. Tissue Eng. 2007;13(4):693-702.
21.
KangJWKooHCHwangSY. Immunomodulatory effects of human amniotic membrane–derived mesenchymal stem cells. J Vet Sci. 2012;13(1):23-31.
22.
KhokharSSharmaNKumarHSoniA. Infection after use of nonpreserved human amniotic membrane for the reconstruction of the ocular surface. Cornea. 2001;20(7):773-774.
23.
KjaergaardNHeinMHyttelL. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol. 2001;94(2):224-229.
24.
KjaergaardNHelmigRBSchonheyderHCUldbjergNHansenESMadsenH. Chorioamniotic membranes constitute a competent barrier to group b streptococcus in vitro. Eur J Obstet Gynecol Reprod Biol. 1999;83(2):165-169.
25.
KmiecikGNiklinskaWKucP. Fetal membranes as a source of stem cells. Adv Med Sci. 2013;58(2):185-195.
26.
KoizumiNJInatomiTJSotozonoCJFullwoodNJQuantockAJKinoshitaS. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000;20(3):173-177.
27.
KoobTJLimJJMasseeMZabekNDenoziereG. Properties of dehydrated human amnion/chorion composite grafts: implications for wound repair and soft tissue regeneration. J Biomed Mater Res B Appl Biomater. 2014;102(6):1353-1362.
28.
KoyanoSFukuiAUchidaSYamadaKAsashimaMSakuragawaN. Synthesis and release of activin and noggin by cultured human amniotic epithelial cells. Dev Growth Differ. 2002;44(2):103-112.
29.
KrishnamurithyGShilpaPNAhmadRESulaimanSNgCLKamarulT. Human amniotic membrane as a chondrocyte carrier vehicle/substrate: in vitro study. J Biomed Mater Res A. 2011;99(3):500-506.
30.
KueckelhausMPhilipJKamelRA. Sustained release of amnion-derived cellular cytokine solution facilitates Achilles tendon healing in rats. Eplasty. 2014;14:e29.
31.
Lange-ConsiglioARossiDTassanSPeregoRCremonesiFParoliniO. Conditioned medium from horse amniotic membrane–derived multipotent progenitor cells: immunomodulatory activity in vitro and first clinical application in tendon and ligament injuries in vivo. Stem Cells Dev. 2013;22(22):3015-3024.
32.
Lange-ConsiglioATassanSCorradettiB. Investigating the efficacy of amnion-derived compared with bone marrow–derived mesenchymal stromal cells in equine tendon and ligament injuries. Cytotherapy. 2013;15(8):1011-1020.
33.
LaurentRNalletAObertLNicodLGindrauxF. Storage and qualification of viable intact human amniotic graft and technology transfer to a tissue bank. Cell Tissue Bank. 2014;15(2):267-275.
34.
LindenmairANurnbergerSStadlerG. Intact human amniotic membrane differentiated towards the chondrogenic lineage. Cell Tissue Bank. 2014;15(2):213-225.
35.
LiuPFGuoLZhaoDW. Study of human acellular amniotic membrane loading bone marrow mesenchymal stem cells in repair of articular cartilage defect in rabbits. Genet Mol Res. 2014;13(3):7992-8001.
36.
LoeffelbeinDJRohlederNHEddicksM. Evaluation of human amniotic membrane as a wound dressing for split-thickness skin-graft donor sites. Biomed Res Int. 2014;2014:572183.
37.
MagattiMDe MunariSVertuaE. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant. 2009;18(8):899-914.
38.
MalhotraCJainAK. Human amniotic membrane transplantation: different modalities of its use in ophthalmology. World J Transplant. 2014;4(2):111-121.
39.
MamedeACCarvalhoMJAbrantesAMLaranjoMMaiaCJBotelhoMF. Amniotic membrane: from structure and functions to clinical applications. Cell Tissue Res. 2012;349(2):447-458.
40.
MarangonFBAlfonsoECMillerDRemondaNMMuallemMSTsengSC. Incidence of microbial infection after amniotic membrane transplantation. Cornea. 2004;23(3):264-269.
41.
MikiT. Amnion-derived stem cells: in quest of clinical applications. Stem Cell Res Ther. 2011;2(3):25.
MohammadiAASeyed JafariSMKiasatM. Effect of fresh human amniotic membrane dressing on graft take in patients with chronic burn wounds compared with conventional methods. Burns. 2013;39(2):349-353.
45.
MuttiniAMattioliMPetrizziL. Experimental study on allografts of amniotic epithelial cells in calcaneal tendon lesions of sheep. Vet Res Commun. 2010;34(suppl 1):S117-S120.
46.
MuttiniAValbonettiLAbateM. Ovine amniotic epithelial cells: in vitro characterization and transplantation into equine superficial digital flexor tendon spontaneous defects. Res Vet Sci. 2013;94(1):158-169.
47.
NiknejadHDeihimTSolati-HashjinMPeiroviH. The effects of preservation procedures on amniotic membrane’s ability to serve as a substrate for cultivation of endothelial cells. Cryobiology. 2011;63(3):145-151.
48.
NiknejadHPaeini-VayghanGTehraniFAKhayat-KhoeiMPeiroviH. Side dependent effects of the human amnion on angiogenesis. Placenta. 2013;34(4):340-345.
49.
NiknejadHPeiroviHJorjaniMAhmadianiAGhanaviJSeifalianAM. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater. 2008;15:88-99.
50.
NogamiMTsunoHKoikeC. Isolation and characterization of human amniotic mesenchymal stem cells and their chondrogenic differentiation. Transplantation. 2012;93(12):1221-1228.
51.
OzbolukSOzkanYOzturkAGulNOzdemirRMYanikK. The effects of human amniotic membrane and periosteal autograft on tendon healing: experimental study in rabbits. J Hand Surg Eur Vol. 2010;35(4):262-268.
52.
OzgenelGY. The effects of a combination of hyaluronic and amniotic membrane on the formation of peritendinous adhesions after flexor tendon surgery in chickens. J Bone Joint Surg Br. 2004;86(2):301-307.
RicciEVanosiGLindenmairA. Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model. Cell Tissue Bank. 2013;14(3):475-488.
55.
SangwanVSBasuS. Antimicrobial properties of amniotic membrane. Br J Ophthalmol. 2011;95(1):1-2.
56.
SchulzeUHampelUSelS. Fresh and cryopreserved amniotic membrane secrete the trefoil factor family peptide 3 that is well known to promote wound healing. Histochem Cell Biol. 2012;138(2):243-250.
57.
ShahAP. Using amniotic membrane allografts in the treatment of neuropathic foot ulcers. J Am Podiatr Med Assoc. 2014;104(2):198-202.
SwanJ. Use of cryopreserved, particulate human amniotic membrane and umbilical cord (AM/UC) tissue: a case series study for application in the healing of chronic wounds. Surg Technol Int. 2014;25:73-78.
60.
TanSLSulaimanSPingguan-MurphyBSelvaratnamLTaiCCKamarulT. Human amnion as a novel cell delivery vehicle for chondrogenic mesenchymal stem cells. Cell Tissue Bank. 2011;12(1):59-70.
61.
TodaAOkabeMYoshidaTNikaidoT. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci. 2007;105(3):215-228.
62.
TuncelUKostakogluNTuranAMarkocFGokceEErkorkmazU. The use of temporalis muscle graft, fresh and cryopreserved amniotic membrane in preventing temporomandibular joint ankylosis after discectomy in rabbits. J Craniomaxillofac Surg. 2014;42(8):1868-1876.
63.
UchidaSInanagaYKobayashiMHurukawaSAraieMSakuragawaN. Neurotrophic function of conditioned medium from human amniotic epithelial cells. J Neurosci Res. 2000;62(4):585-590.
64.
WarnerMLasyoneL. An open-label, single-center, retrospective study of cryopreserved amniotic membrane and umbilical cord tissue as an adjunct for foot and ankle surgery. Surg Technol Int. 2014;25:251-255.
65.
WeiJPNawataMWakitaniS. Human amniotic mesenchymal cells differentiate into chondrocytes. Cloning Stem Cells. 2009;11(1):19-26.
66.
WerberBMartinE. A prospective study of 20 foot and ankle wounds treated with cryopreserved amniotic membrane and fluid allograft. J Foot Ankle Surg. 2013;52(5):615-621.
67.
WillettNJThoteTLinAS. Intra-articular injection of micronized dehydrated human amnion/chorion membrane attenuates osteoarthritis development. Arthritis Res Ther. 2014;16(1):R47.
68.
WolbankSPeterbauerAFahrnerM. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 2007;13(6):1173-1183.
69.
ZelenCM. An evaluation of dehydrated human amniotic membrane allografts in patients with DFUs. J Wound Care. 2013;22(7):347-348, 350-341.
70.
ZelenCMPokaAAndrewsJ. Prospective, randomized, blinded, comparative study of injectable micronized dehydrated amniotic/chorionic membrane allograft for plantar fasciitis—a feasibility study. Foot Ankle Int. 2013;34(10):1332-1339.
71.
ZelenCMSerenaTEDenoziereGFetterolfDE. A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers. Int Wound J. 2013;10(5):502-507.
72.
ZelenCMSerenaTESnyderRJ. A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion/chorion membrane allograft in the management of diabetic foot ulcers. Int Wound J. 2014;11(2):122-128.
73.
ZelenCMSnyderRJSerenaTELiWW. The use of human amnion/chorion membrane in the clinical setting for lower extremity repair: a review. Clin Podiatr Med Surg. 2015;32(1):135-146.
74.
ZhangYLiCJiangX. Human placenta–derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells. Exp Hematol. 2004;32(7):657-664.
75.
ZhouJYuGCaoCPangJChenX. Bone morphogenetic protein-7 promotes chondrogenesis in human amniotic epithelial cells. Int Orthop. 2011;35(6):941-948.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
